On June 16, 2021, the US National Science Foundation’s (NSF) Division of Biological Infrastructure, via the NSF mid-scale RI-2 program, announced an award (#1946970) to create a novel ‘Network for Advanced NMR’ (NAN). The NAN Principal Investigator is Professor Jeffrey Hoch at the University of Connecticut Health Center, with co-Principal Investigators Professors Chad Rienstra and Katherine Henzler-Wildman at the University of Wisconsin-Madison, and co-Principal Investigator Professor Arthur Edison at the University of Georgia.
Bruker would like to commend the Principal Investigators of NAN for their vision and leadership, and congratulate them again on this major NSF biological infrastructure award.
Link to: NSF Award Search: Award # 1946970 - Mid-scale RI-2 Consortium: Network for Advanced NMR
The NSF Award states:
This award will support the establishment of a geographically distributed Network for Advanced NMR (NAN) in the U.S. to provide ultra-high field NMR spectrometers to allow users to tackle important and diverse scientific problems and to educate and train the next generation of scientists and engineers. Scientific research areas enabled by these systems cover a wide range of problems in structural biology, dynamics and function of different biological systems from molecules to whole cells and tissues, complex mixtures, metabolomics, and natural products. Non-biological applications include, but are not limited to, amorphous materials, battery components, pharmaceutical ingredients, nanomaterials, surface coatings, and catalysts. […]
The NAN will operate by a hub and spoke model that dynamically adapts to meet evolving community needs. The hub at the University of Connecticut will facilitate access to state-of-the-art NMR instrumentation, experimental protocols, and experts by US researchers. Existing cyberinfrastructure will be leveraged and expanded to serve the storage, analysis, and data-reuse needs for a large community of researchers. The project also includes plans to purchase two 1.1 GHz NMR spectrometers for installation at the NAN spoke locations. One system will be installed at University of Wisconsin for solid-state NMR research. The second system will be installed at the University of Georgia and be dedicated to solution NMR studies.
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
Director, Investor Relations & Corporate Development
T: +1 (978) 663-3660 x1479
Thorsten Thiel, Ph.D.
VP of Group Marketing
T: +49 (721) 5161–6500